Game On: Topokine Initiates Late-Stage Trial of XAF5 Ointment for Reining in Undereye Bags
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Powered by five integrated technologies, the multi-platform is designed to support a range of treatments for various skin types and conditions.
Dynavisc adhesion barrier gel is designed to reduce the formation of adhesions following tendon and peripheral nerve related surgical procedures.
Researchers from Florida Atlantic University have received a four-year, $1.2 million grant from the National Science Foundation to empower amputees to maximize their individual potential for controlling the full dexterity of artificial hands.
Gilbert, Ariz.-based DrSkin Med Spa, which offers both noninvasive and minimally invasive medical aesthetic treatments, is now offering AviClear acne treatment.
APONVIE, from Heron Therapeutics, is an injectable emulsion for IV use in adults for the prevention of postoperative nausea and vomiting.